BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CITI Program - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://about.citiprogram.org
X-WR-CALDESC:Events for CITI Program
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251010T093000
DTEND;TZID=America/New_York:20251010T170000
DTSTAMP:20260405T181942
CREATED:20250923T141320Z
LAST-MODIFIED:20251015T184712Z
UID:59139-1760088600-1760115600@about.citiprogram.org
SUMMARY:FDA/The Osteosarcoma Institute (OSI) Workshop: Advancing Osteosarcoma Drug Development – Connecting Research and Regulatory Pathways for Improved Outcomes
DESCRIPTION:The FDA Oncology Center of Excellence (OCE) and The Osteosarcoma Institute (OSI) are hosting a workshop focused on addressing key challenges in osteosarcoma drug development. This event aims to bring together stakeholders from patient advocacy\, academic research\, regulatory agencies\, and the biopharmaceutical industry to identify barriers and collaborate on solutions for advancing clinical therapies. \nTopics Will Include: \n\nIdentifying promising drug candidates\nAddressing molecular heterogeneity\nOptimizing clinical trial endpoints\nIncorporating innovative study designs\n\nEvent Goals: \n\nTo convene key stakeholders to share perspectives on the challenges to\, and identify opportunities for\, advancing clinical development of therapies for osteosarcoma through collaboration and communication.\nTo identify opportunities to increase efficiency within osteosarcoma drug development.\nTo develop strategies to address the most significant challenges in clinical trials design and implementation in osteosarcoma.\n\nVisit the event page for more information.
URL:https://about.citiprogram.org/event/fda-the-osteosarcoma-institute-osi-workshop-advancing-osteosarcoma-drug-development-connecting-research-and-regulatory-pathways-for-improved-outcomes/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/09/fda-osi-workshop-oct-10.png
END:VEVENT
END:VCALENDAR